United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-3.81%
2025 (actual)
ROA
-2.37%
2025 (actual)
Gross Margin
41.4%
2025 (actual)
Net Margin
-3.76%
2025 (actual)
Total Assets
$42,532.45K
2025 (actual)
Net Income
-$1,040.03K
2025 (actual)
Valuation
$55,855.51K
2026 (forecast)
Stock Price
$6.15
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+18.4 pt
Company
Sector average
ROA
+14.6 pt
Company
Gross Margin
-15.2 pt
Company
Sector average
Net Margin
+26.4 pt
Company
Total Assets
+190.9%
Company
Sector average (own scale)
Net Income
+1,471.7%
Company
Valuation
+29.2%
Company
Stock Price
+29.3%
Company
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for IMMUCELL CORP /DE/? It covers the balance sheet, income statement, cash flow and Equlion model projections.